Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-13

FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's generic version of fluticasone propionate and salmeterol inhalation for the maintenance treatment of asthma and chronic obstructive pulmonar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Propionate and Salmeterol (Fluticasone Propionate and Salmeterol)

Snippet

ORIG AP for FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)